The HERA W10 Elite ultrasound platform provides enhanced visualization features and artificial intelligence (AI)-aided measurement capabilities.
Could the HERA W10 Elite reinvent ultrasound imaging in obstetrics and gynecology care?
The newly launched ultrasound system offers 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow™ feature and a large organic light-emitting diode (OLED) display that provides improved characterization of diverse ultrasound images, according to Samsung, the manufacturer of the HERA W10 Elite system.
Samsung said the HERA W10 Elite also has HeartAssist™, an artificial intelligence (AI)-enhanced feature that provides automated measurement views to facilitate diagnosis of the fetal heart.
(Editor’s note: For related content, see “Adjunctive AI Software for Cardiac Ultrasound Gets FDA Nod” and “Emerging Trends in AI, Ultrasound and OB/GYN Care.”)
Other planned features, pending 510(k) clearance from the Food and Drug Administration (FDA), include a new EV2-12 transducer that allows imaging of the fetal heart and brain starting at eight weeks and Biometry Assist™, which allows one-click measurement of fetal growth parameters.
“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to obstetrics and gynecology with sophisticated image processing and an ergonomic-friendly design,” noted Tracy Bury, Women’s Health Ultrasound Business Leader with Boston Imaging, the United States headquarters for Samsung’s digital radiography and ultrasound business.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.